Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Emilie Kottenmeier, MSc
Johnson & Johnson Franchise Health Economics and Market Access
Poster(s):
(159) Readmission Rates and Costs Associated with the Use of Enterprise 2 and Neuroform Atlas Stents for Unruptured Intracranial Aneurysms: A Comparative Real-World Analysis
Tuesday, August 27, 2024
8:00 AM – 6:00 PM
CEST